Management of refractory vasodilatory shock
Refractory shock is a lethal manifestation of cardiovascular failure defined by an inadequate
hemodynamic response to high doses of vasopressor medications. Approximately 7% of …
hemodynamic response to high doses of vasopressor medications. Approximately 7% of …
[HTML][HTML] Vasoplegic syndrome following cardiothoracic surgery—review of pathophysiology and update of treatment options
LW Busse, N Barker, C Petersen - Critical Care, 2020 - Springer
Vasoplegic syndrome is a common occurrence following cardiothoracic surgery and is
characterized as a high-output shock state with poor systemic vascular resistance. The …
characterized as a high-output shock state with poor systemic vascular resistance. The …
Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial
Importance β-Blocker therapy may control heart rate and attenuate the deleterious effects of
β-adrenergic receptor stimulation in septic shock. However, β-Blockers are not traditionally …
β-adrenergic receptor stimulation in septic shock. However, β-Blockers are not traditionally …
Levosimendan for the prevention of acute organ dysfunction in sepsis
Background Levosimendan is a calcium-sensitizing drug with inotropic and other properties
that may improve outcomes in patients with sepsis. Methods We conducted a double-blind …
that may improve outcomes in patients with sepsis. Methods We conducted a double-blind …
Vasopressin versus Norepinephrine in Patients with Vasoplegic Shock after Cardiac Surgery: The VANCS Randomized Controlled Trial
LA Hajjar, JL Vincent, FR Barbosa Gomes Galas… - …, 2017 - pubs.asahq.org
Background Vasoplegic syndrome is a common complication after cardiac surgery and
impacts negatively on patient outcomes. The objective of this study was to evaluate whether …
impacts negatively on patient outcomes. The objective of this study was to evaluate whether …
Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: a systematic review and …
Importance Vasopressin is an alternative to catecholamine vasopressors for patients with
distributive shock—a condition due to excessive vasodilation, most frequently from severe …
distributive shock—a condition due to excessive vasodilation, most frequently from severe …
[HTML][HTML] Sepsis: frontiers in diagnosis, resuscitation and antibiotic therapy
Sepsis is a major growing global burden and a major challenge to intensive care clinicians,
researchers, guideline committee members and policy makers, because of its high and …
researchers, guideline committee members and policy makers, because of its high and …
Effect of dexmedetomidine on mortality and ventilator-free days in patients requiring mechanical ventilation with sepsis: a randomized clinical trial
Y Kawazoe, K Miyamoto, T Morimoto, T Yamamoto… - Jama, 2017 - jamanetwork.com
Importance Dexmedetomidine provides sedation for patients undergoing ventilation;
however, its effects on mortality and ventilator-free days have not been well studied among …
however, its effects on mortality and ventilator-free days have not been well studied among …
[HTML][HTML] Intra-abdominal sepsis: new definitions and current clinical standards
A Hecker, M Reichert, CJ Reuß, T Schmoch… - … archives of surgery, 2019 - Springer
Purpose The abdomen is the second most common source of sepsis and is associated with
unacceptably high morbidity and mortality. Recently, the essential definitions of sepsis and …
unacceptably high morbidity and mortality. Recently, the essential definitions of sepsis and …
Higher versus lower blood pressure targets for vasopressor therapy in shock: a multicentre pilot randomized controlled trial
Purpose In shock, hypotension may contribute to inadequate oxygen delivery, organ failure
and death. We conducted the Optimal Vasopressor Titration (OVATION) pilot trial to inform …
and death. We conducted the Optimal Vasopressor Titration (OVATION) pilot trial to inform …